Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 July 2025 to Question 63541 on Autism: Foetal Valproate Spectrum Disorder, if she will take steps to collate this information centrally.

Research already exists that shows evidence of an increased risk for children of neurodevelopmental disorders, such as autism, when exposed to Valproate during pregnancy. This includes the Medicines & Healthcare products Regulatory Agency’s publication, Valproate: review of safety data and expert advice on management of risks.

As this link is already identified in the evidence and research available, NHS England has no plans to collate further information about the number of children with autism also diagnosed with foetal valproate syndrome.